We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On June 11, 2012, the Delaware Chancery Court ruled that a shareholder derivative case could proceed against the directors of Allergan, Inc., even after a federal court in California had dismissed with prejudice a parallel action based on identical claims
Three former Purdue executives, including the company's former general counsel, are appealing their 12-year exclusion from federal health care programs by the Department of Health and Human Services ("HHS") Office of Inspector General ("OIG"
On November 21, 2011, two former executives of Synthes, Inc. were each sentenced to prison terms of nine months with three months of supervised release, and a third executive was sentenced to a five-month prison term with seven months of supervised release
